Home LiteratureArticle Details
PMID: 4398631 Published · ppublish English Journal Article

On the differential cytotoxicity of actinomycin D.

The Journal of cell biology ·Vol. 50 ·No. 3 ·1971-09-00 ·Pages 746-61

Sawicki SG, Godman GC

Abstract

Actinomycin D (AMD) at concentrations that inhibit cellular RNA synthesis by 85% or more causes an acute phase of lethal cell degeneration in HeLa cultures beginning as early as 3 hr after drug exposure, resulting in the nearly complete loss of viable cells by 12 hr. The loss of cells during this acute phase of lethality is closely dose dependent. Vero, WI38, or L cells are not susceptible to this early acute cyto-intoxication by AMD, and may begin to die only after 1-2 days. Differential susceptibility to acute cyto-intoxication by AMD, or other inhibitors of RNA synthesis (daunomycin or nogalamycin), among different types of cultured cells is analogous to that observed in vivo in certain tissues and tumors, and cannot be accounted for by differences in the effect of AMD on RNA, DNA, or protein syntheses, or by the over-all loss of preformed RNA. Actinomycin D in a dose that inhibits RNA synthesis causes an equivalent loss of the prelabeled RNA in all the cell types studied. Inhibition of protein synthesis with streptovitacin A or of DNA synthesis with hydroxyurea does not cause acute lethal injury in HeLa cells as does inhibition of RNA synthesis. Furthermore, since Vero or L cells divide at about the same rate as HeLa cells, no correlation can be drawn between the rate of cell proliferation and susceptibility to the cytotoxicity of AMD. Susceptibile cells are most vulnerable to intoxication by AMD in the G(1)-S interphase or early S phase. Inhibition of protein synthesis (which protects cells against damage by other agents affecting DNA) does not protect against AMD-induced injury. Although HeLa cells bind more AMD at a given dose than Vero or L cells, the latter cell types, given higher doses, can be made to bind proportionally more AMD without succumbing to acute cyto-intoxication. It is suggested that the differential susceptibility of these cell types to acute poisoning by AMD may reflect differences among various cells in the function or stability of certain RNA species not directly involved in translation whose presence is vital to cells. In HeLa cells, these critical species of RNA are presumed to have a short half-life.

MeSH Terms
Animals Carbon Isotopes Cell Division/drug effects Cell Line Cell Survival/drug effects Cells, Cultured/drug effects Culture Techniques DNA/antagonists & inhibitors,biosynthesis DNA, Neoplasm/antagonists & inhibitors,biosynthesis Dactinomycin/metabolism,pharmacology Half-Life Haplorhini HeLa Cells/metabolism Humans Hydroxyurea/pharmacology Kidney L Cells Lung Methods Mice Protein Biosynthesis Proteins/antagonists & inhibitors RNA/antagonists & inhibitors,biosynthesis RNA, Neoplasm/antagonists & inhibitors,biosynthesis Streptovaricin/pharmacology Time Factors Uridine/metabolism
Chemicals
Carbon Isotopes DNA, Neoplasm Proteins RNA, Neoplasm Streptovaricin Dactinomycin RNA DNA Uridine Hydroxyurea
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Sawicki S G
Godman G C
References (45)
45 references, click to expand
  1. Giant-size rapidly labeled nuclear ribonucleic acid and cytoplasmic messenger ribonucleic acid in immature duck erythrocytes.
    J Mol Biol. 1966 Sep;20(1):145-82 PMID: 5970657
  2. Nuclear-cytoplasmic interaction in DNA synthesis.
    Science. 1967 Jan 27;155(3761):469-70 PMID: 6015697
  3. EFFECTS OF ACTINOMYCIN D ON THE SALIVARY GLANDS OF THE RAT.
    Life Sci. 1964 Nov;3:1239-47 PMID: 14231774
  4. Analytical studies on nuclear ribonucleic acid using polyacrylamide gel electrophoresis.
    Biochemistry. 1968 Feb;7(2):659-68 PMID: 5644137
  5. Rapidly labeled HeLa cell nuclear RNA. I. Identification by zone sedimentation of a heterogeneous fraction separate from ribosomal precursor RNA.
    J Mol Biol. 1966 Aug;19(2):349-61 PMID: 5969070
  6. Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle.
    Science. 1965 Dec 24;150(3704):1729-31 PMID: 5858026
  7. Small molecular weight monodisperse nuclear RNA.
    J Mol Biol. 1968 Dec;38(3):289-304 PMID: 5718554
  8. Evaluation of 4-(2-hydroxyethyl)-1-piperazineëthanesulfonic acid (HEPES) as a tissue culture buffer.
    Proc Soc Exp Biol Med. 1969 Jan;130(1):305-10 PMID: 5762514
  9. High molecular weight nonribosomal-type nuclear RNA and cytoplasmic messenger RNA in HeLa cells.
    Proc Natl Acad Sci U S A. 1966 Aug;56(2):616-23 PMID: 5229981
  10. Actinomycin D: drug concentrations and actions in mouse tissues and tumors.
    Cancer Res. 1968 Feb;28(2):192-7 PMID: 5238590
  11. Differential effects of hydroxyurea on survival of proliferating cells in vivo.
    Cancer Res. 1969 Jan;29(1):136-9 PMID: 5763974
  12. Demonstration of an unstable RNA and of a precursor to ribosomal RNA in HeLa cells.
    Proc Natl Acad Sci U S A. 1963 Feb 15;49:240-8 PMID: 13991616
  13. Inhibition of DNA synthesis in HeLa cells by hydroxyurea.
    Cancer Res. 1967 Jan;27(1):124-9 PMID: 6020353
  14. Different lethal effects of mitomycin C and actinomycin D during the division cycle of HeLa cells.
    J Cell Biol. 1968 Sep;38(3):477-82 PMID: 5664219
  15. The rapid acceleration of hepatic nuclear ribonucleic acid breakdown by actinomycin but not by ethionine.
    J Biol Chem. 1968 Sep 10;243(17):4479-85 PMID: 5684004
  16. Actinomycin binding of normal and phytohaemagglutinin stimulated lymphocytes.
    Exp Cell Res. 1969 Apr;55(1):120-2 PMID: 5780784
  17. Actinomycin and nucleic acid function.
    Prog Nucleic Acid Res Mol Biol. 1964;3:183-234 PMID: 4157816
  18. Repair of potentially lethal damage in x-irradiated HeLa cells.
    Radiat Res. 1966 Nov;29(3):413-32 PMID: 4224300
  19. Cell killing by actinomycin D in relation to the growth cycle of chinese hamster cells.
    J Cell Biol. 1969 Aug;42(2):366-77 PMID: 5792326
  20. The reactivation of the red cell nucleus.
    J Cell Sci. 1967 Mar;2(1):23-32 PMID: 6031005
  21. FUNCTION OF THE SHORT-LIVED RIBONUCLEIC ACID IN THE CELL NUCLEUS.
    Nature. 1964 Feb 29;201:863-7 PMID: 14132772
  22. Control of specific gene expression in higher organisms. Expression of mammalian genes may be controlled by repressors acting on the translation of messenger RNA.
    Science. 1969 Dec 19;166(3912):1474-80 PMID: 17655040
  23. Interphase death of cultured mammalian cells (L5178Y).
    Radiat Res. 1969 Aug;39(2):361-73 PMID: 4183786
  24. Use of low concentrations of actinomycin D in the study of RNA synthesis in Ehrlich ascites cells.
    J Mol Biol. 1966 Sep;20(1):63-73 PMID: 6008160
  25. Patterns of RNA metabolism in a differentiated cell: a rapidly labeled, unstable 60S RNA with messenger properties in duck erythroblasts.
    Proc Natl Acad Sci U S A. 1966 Nov;56(5):1571-8 PMID: 5230317
  26. Changes in deoxyribonucleo-protein during spermiogenesis in the bull. 3 H-Actinomycin D binding capacity.
    Exp Cell Res. 1969 Dec;58(2):435-8 PMID: 5404081
  27. Studies on nucleolar 4 to 6 S ribonucleic acid of Novikoff hepatoma cells.
    J Biol Chem. 1968 Apr 10;243(7):1368-75 PMID: 4296684
  28. Rapidly labeled HeLa cell nuclear RNA. II. Base composition and cellular localization of a heterogeneous RNA fraction.
    J Mol Biol. 1966 Aug;19(2):362-72 PMID: 5969071
  29. Initiation of vaccinia virus infection in actinomycin D-pretreated cells.
    J Virol. 1968 Jul;2(7):678-85 PMID: 5723524
  30. Reversible effect of actinomycin D on nucleoli of Amoeba discoides: nuclear transplantation study.
    Nature. 1969 Mar 15;221(5185):1073-4 PMID: 5774406
  31. Age responses of cultured mammalian cells to cytotoxic drugs.
    Cancer Res. 1970 May;30(5):1397-408 PMID: 5426942
  32. Pulse labeling of RNA of mammalian cells.
    Proc Natl Acad Sci U S A. 1970 Apr;65(4):876-83 PMID: 5266157
  33. BIOSYNTHESIS OF MESSENGER AND RIBOSOMAL RIBONUCLEIC ACIDS IN THE NUCLEOLOCHROMOSOMAL APPARATUS OF ANIMAL CELLS.
    Nature. 1963 Dec 28;200:1291-4 PMID: 14098472
  34. Hydroxyurea. I. Acute cell death in proliferating tissues in rats.
    Cancer Res. 1967 Jan;27(1):61-75 PMID: 6020366
  35. Low molecular weight RNA associated with 28 s nucleolar RNA.
    J Mol Biol. 1970 Feb 14;47(3):505-15 PMID: 5418169
  36. Evidence for ribonucleic acid molecules restricted to the cell nucleus.
    Biochemistry. 1967 Jan;6(1):283-9 PMID: 6030325
  37. Kinetics of the in vitro inhibition of transcription by actinomycin.
    J Mol Biol. 1970 Jun 14;50(2):421-38 PMID: 5476920
  38. Effects of actinomycin D on avian myeloblast and BAI strain A virus RNA synthesis in vitro.
    Cancer Res. 1966 Sep;26(9):1839-46 PMID: 4288668
  39. Studies on unbalanced growth in synchronized HeLa cells.
    Cancer Res. 1968 Dec;28(12):2443-7 PMID: 5728153
  40. Localization and kinetics of formation of nuclear heterodisperse RNA, cytoplasmic heterodisperse RNA and polyribosome-associated messenger RNA in HeLa cells.
    J Mol Biol. 1968 May 28;34(1):49-60 PMID: 4106524
  41. Actinomycin D: effects on mouse L-cells.
    Biophys J. 1969 Dec;9(12):1427-45 PMID: 5357735
  42. The turnover of nuclear DNA-like RNA in HeLa cells.
    J Cell Biol. 1968 Oct;39(1):112-8 PMID: 5678443
  43. Stimulation of nuclear DNA and RNA synthesis by cytoplasmic extracts in vitro.
    Biochem Biophys Res Commun. 1968 Jan 25;30(2):166-72 PMID: 5641865
  44. THE CELLULAR SITES OF SYNTHESIS OF RIBOSOMAL AND 4S RNA.
    Proc Natl Acad Sci U S A. 1962 Dec;48(12):2179-86 PMID: 16591032
  45. Actinomycin D effects on nucleic acids during tumor regression.
    Cancer Res. 1968 Mar;28(3):445-51 PMID: 5238558
Article Info
Journal
The Journal of cell biology
Abbr.
J Cell Biol
ISSN
0021-9525
Published
1971-09-00
Pages
746-61
Language
English
Region
United States
NLM ID
0375356
PMCID
PMC2108313
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com